DK0681470T3 - Sammensætning af rekombinant, levende subunitvaccine og fremgangsmåde til fremstilling heraf - Google Patents

Sammensætning af rekombinant, levende subunitvaccine og fremgangsmåde til fremstilling heraf

Info

Publication number
DK0681470T3
DK0681470T3 DK94905751.7T DK94905751T DK0681470T3 DK 0681470 T3 DK0681470 T3 DK 0681470T3 DK 94905751 T DK94905751 T DK 94905751T DK 0681470 T3 DK0681470 T3 DK 0681470T3
Authority
DK
Denmark
Prior art keywords
preparation
composition
subunit vaccine
recombinant live
recombinant
Prior art date
Application number
DK94905751.7T
Other languages
English (en)
Inventor
Vincent Ganne
Original Assignee
S E P P I C Societe Dexploitat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by S E P P I C Societe Dexploitat filed Critical S E P P I C Societe Dexploitat
Application granted granted Critical
Publication of DK0681470T3 publication Critical patent/DK0681470T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
DK94905751.7T 1993-01-29 1994-01-28 Sammensætning af rekombinant, levende subunitvaccine og fremgangsmåde til fremstilling heraf DK0681470T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9300942A FR2700957B1 (fr) 1993-01-29 1993-01-29 Composition de vaccin sous-unitaire recombinant vivant et procédé de préparation.

Publications (1)

Publication Number Publication Date
DK0681470T3 true DK0681470T3 (da) 1996-08-12

Family

ID=9443503

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94905751.7T DK0681470T3 (da) 1993-01-29 1994-01-28 Sammensætning af rekombinant, levende subunitvaccine og fremgangsmåde til fremstilling heraf

Country Status (8)

Country Link
EP (1) EP0681470B1 (da)
JP (2) JPH08505866A (da)
CA (1) CA2154902A1 (da)
DE (1) DE69400312T2 (da)
DK (1) DK0681470T3 (da)
ES (1) ES2089923T3 (da)
FR (1) FR2700957B1 (da)
WO (1) WO1994016681A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707896B1 (fr) * 1993-07-22 1995-09-01 Chemoxal Sa Procédé de traitement d'un article et nouvelle solution aqueuse de peroxyde d'hydrogène.
FR2717694B1 (fr) * 1994-03-22 1996-05-03 Seppic Sa Une composition comprenant un plasmide recombinant et ses utilisations comme vaccin et médicament.
FR2754715B1 (fr) * 1996-10-18 1998-11-13 Seppic Sa Adjuvant, notamment sous forme d'une emulsion contenant un cation metallique trivalent et composition vaccinale le comprenant
US6117432A (en) * 1995-04-20 2000-09-12 Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
US5849303A (en) * 1995-06-07 1998-12-15 American Home Products Corporation Recombinant feline Immunodeficiency virus subunit vaccines employing baculoviral-expressed envelope glycoproteins derived from isolate NCSU-1 and their use against feline immunodeficiency virus infection
FR2754182B1 (fr) * 1996-10-07 1998-11-06 Seppic Sa Nouvelles compositions vaccinales comportant comme adjuvant un compose sympathomimetique
UA78180C2 (uk) 1997-10-03 2007-03-15 Меріаль Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
FR2775601B1 (fr) 1998-03-03 2001-09-21 Merial Sas Vaccins vivants recombines et adjuves
FR2800280B1 (fr) 1999-10-29 2003-09-19 Seppic Sa Nouvelle composition vaccinale et utilisation d'agents tensioactifs comme adjuvants d'immunite
FR2809961B1 (fr) * 2000-06-09 2004-12-03 Seppic Sa Utilisation d'ethers de sucres, comme adjuvants d'immunite dans les compositions vaccinales, compositions therapeutiques les renfermant et leur utilisation comme vaccins
JP2002030098A (ja) * 2000-07-17 2002-01-29 Institute Of Immunology Co Ltd バキュロウィルスの発芽ウイルスからウイルスエンベロープを回収する方法
FR2814956B1 (fr) * 2000-10-06 2003-01-24 Seppic Sa Nouvelle composition vaccinale, procede pour sa preparation, utilisation comme composition injectale en medecine humaine ou veterinaire et nouveau procede de conservation
US20040071733A1 (en) * 2001-02-05 2004-04-15 Hiroshi Takaku Baculovirus vector vaccine
AU2008202282B8 (en) * 2001-07-26 2009-08-13 Agresearch Limited Immunogenic Compositions
WO2003009868A1 (en) * 2001-07-26 2003-02-06 Otago Innovation Limited Antigenic compositions
WO2003020322A1 (de) * 2001-09-04 2003-03-13 DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung Vektor zur induktion einer immunantwort
FR2922767B1 (fr) 2007-10-24 2009-12-18 Seppic Sa Procede de preparation d'une composition vaccinale comprenant au moins un antigene et au moins un adjuvant.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8301996A (nl) * 1983-06-06 1985-01-02 Duphar Int Res Werkwijze ter bereiding van geadjuveerde levende vaccins en aldus verkregen geadjuveerde levende vaccins.
FR2649013B1 (fr) * 1989-07-03 1991-10-25 Seppic Sa Vaccins et vecteurs de principes actifs fluides contenant une huile metabolisable
EP0563323A4 (en) * 1990-12-19 1996-02-28 Epitope Inc Hiv reverse transcriptase vaccine

Also Published As

Publication number Publication date
WO1994016681A1 (fr) 1994-08-04
EP0681470B1 (fr) 1996-07-17
ES2089923T3 (es) 1996-10-01
JP2004137283A (ja) 2004-05-13
EP0681470A1 (fr) 1995-11-15
DE69400312T2 (de) 1996-11-21
JPH08505866A (ja) 1996-06-25
DE69400312D1 (de) 1996-08-22
CA2154902A1 (fr) 1994-08-04
FR2700957A1 (fr) 1994-08-05
FR2700957B1 (fr) 1995-03-03

Similar Documents

Publication Publication Date Title
DK0681470T3 (da) Sammensætning af rekombinant, levende subunitvaccine og fremgangsmåde til fremstilling heraf
DK0861089T3 (da) Metoder og sammensætninger til indgivelse af monomere proteiner
DK0622408T3 (da) Sammensætning og fremgangsmåde til fremstilling af gelatinfrie, bløde kapsler
NO973046D0 (no) Elastiske sementsammensetninger og fremgangsmåte
NO973632D0 (no) Herdingsretarderte sementsammensetninger og fremgangsmåter til deres fremstilling
DK0467185T3 (da) Oligomerer, deres anvendelser og formuleringer
IS1850B (is) Kristölluð a-fjölgervingsmynd af indól afleiðu, notkun hennar, aðferð til framleiðslu og lyfjaefnablanda
NO964583D0 (no) Lettvekts brönnsementsammensetninger og fremgangsmåter
DK0954588T3 (da) OB fusionsprotein-sammensætninger og fremgangsmåder
DK0946190T3 (da) Fremgangsmåder og sammensætninger til stimulering af neuritvækst
DK0500807T3 (da) Præparat og fremgangsmåde til befugtning af væv
DK0797431T3 (da) Aerosolformuleringer af peptider og proteiner
DK0518521T3 (da) Foringselement til foring af forgreningsrør og fremgangsmåde til fremstilling heraf
NO922275L (no) Aryletere, deres fremstilling og fremgangsmaate for behandling
ID17860A (id) Komposisi vaksin
DK44891D0 (da) Partikelformet mineralsaltkomposition og fremgangsmaade til fremstilling af samme
DK0384323T4 (da) Sammensætning og fremgangsmåde til forstærkning af en fiskevaccines virkning
DK0884358T3 (da) Smidige og slagstærke sammensætninger på basis af polyvinylidenfluorid og fremgangsmåde til deres fremstilling
DK10288A (da) Fremgangsmaade til isolering og rensning af p. falciparum cs-proteinvaccine udtrykt i rekombineret e. coli
DK0791591T3 (da) Benzothiophener, formuleringer indeholdende samme og fremgangsmåder til deres fremstilling
DK0970077T3 (da) Forbedret fremgangsmåde til fremstilling af thiazolidindioner og nye thiazolidindioner
NO933435D0 (no) Piperidinderivater, deres fremstilling og anvendelse
DK147492D0 (da) Fremgangsmaade og anlaeg til fremstilling af cementklinker
DK1131414T3 (da) Stabile, svækkede rabiesvirusmutanter og levende vacciner deraf
DK0776899T3 (da) Mellemprodukter og deres anvendelse til fremstilling af N,N'-forbundne bisindolylmaleimider